Stay updated on Insulin Degludec Titration in Mobile Insulin Dosing System Clinical Trial
Sign up to get notified when there's something new on the Insulin Degludec Titration in Mobile Insulin Dosing System Clinical Trial page.

Latest updates to the Insulin Degludec Titration in Mobile Insulin Dosing System Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe NIH website transition announcement banner, including its link to updates and FAQs and its note about terminology, is no longer displayed.SummaryDifference1%

- Check14 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check21 days agoChange DetectedA notice announces that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” across its content.SummaryDifference1%

- Check28 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check35 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check56 days agoChange DetectedAn error page (403 Forbidden) now appears where the study record content used to be, with site chrome (header/footer) still visible. The change effectively removes access to the study details from the public page, replacing it with an error notice and basic navigation.SummaryDifference20%

Stay in the know with updates to Insulin Degludec Titration in Mobile Insulin Dosing System Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Insulin Degludec Titration in Mobile Insulin Dosing System Clinical Trial page.